An approved label is also different from a research protocol
Gentica de la EM: An epidemiological and molecular perspective
Individuals continue taking the medication even when it causes financial, relationship, or legal problems
Given that sarcopenia is a key component of CHE pathophysiology, it is reasonable to test for CHE in patients with reduced muscle mass or muscle strength [44,45,46]
Regulation of cell behavior by matricellular proteins
During the COVID-19 pandemic and after, our clinic has seen thousands of patients of all ages and backgrounds, we also extended our hours to meet the urgent needs of our community, allowing us to handle a higher volume of patients and ensure everyone received the care they needed